Gain Therapeutics
Latest round
- Series B
Last raised
- Jul 2020
Total raised
- $13M
Investors
- 4
About Gain Therapeutics
Gain Therapeutics, Inc.Founded in 2017 and headquartered in Bethesda, US, Gain Therapeutics is dedicated to advancing therapies for neurodegenerative diseases. The company has not reported any significant changes in its business strategy or operations since its inception. Lorenzo Leoni, the founder, has a history in biotechnology, while Matthias Alder serves as the CEO.Gain Therapeutics develops innovative therapies targeting GBA-Parkinson’s disease and other neurodegenerative disorders. Their lead candidate, GT-02287, is in a Phase I clinical trial and aims to modulate protein functions using their AI-supported Magellan™ platform. The company aims to expand into North American and European markets, focusing on providing advanced treatments for neurodegenerative diseases, aligning with their strategy for growth through innovation and collaboration.
Who invested in Gain Therapeutics
4 investors across 2 rounds
See all investors in Gain Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gain Therapeutics
Who invested in Gain Therapeutics?
Gain Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gain Therapeutics raised?
Gain Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Gain Therapeutics last raise money?
Gain Therapeutics's most recent round on record is a Series B, in Jul 2020.
What does Gain Therapeutics do?
Gain Therapeutics is a biotechnology company.
Where is Gain Therapeutics headquartered?
Gain Therapeutics is headquartered in Bethesda, US.
Which VCs invest in companies like Gain Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Gain Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Gain Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.